Literature DB >> 32317241

Conventional vs machine learning-based treatment planning in prostate brachytherapy: Results of a Phase I randomized controlled trial.

Alexandru Nicolae1, Mark Semple1, Lin Lu2, Mackenzie Smith2, Hans Chung3, Andrew Loblaw3, Gerard Morton3, Lucas Castro Mendez3, Chia-Lin Tseng3, Melanie Davidson1, Ananth Ravi4.   

Abstract

PURPOSE: The purpose of this study was to evaluate the noninferiority of Day 30 dosimetry between a machine learning-based treatment planning system for prostate low-dose-rate (LDR) brachytherapy and the conventional, manual planning technique. As a secondary objective, the impact of planning technique on clinical workflow efficiency was also evaluated.
MATERIALS AND METHODS: 41 consecutive patients who underwent I-125 LDR monotherapy for low- and intermediate-risk prostate cancer were accrued into this single-institution study between 2017 and 2018. Patients were 1:1 randomized to receive treatment planning using a machine learning-based prostate implant planning algorithm (PIPA system) or conventional, manual technique. Treatment plan modifications by the radiation oncologist were evaluated by computing the Dice coefficient of the prostate V150% isodose volume between either the PIPA-or conventional-and final approved plans. Additional evaluations between groups evaluated the total planning time and dosimetric outcomes at preimplant and Day 30.
RESULTS: 21 and 20 patients were treated using the PIPA and conventional techniques, respectively. No significant differences were observed in preimplant or Day 30 prostate D90%, V100%, rectum V100, or rectum D1cc between PIPA and conventional techniques. Although the PIPA group had a larger proportion of patients with plans requiring no modifications (Dice = 1.00), there was no significant difference between the magnitude of modifications between each arm. There was a large significant advantage in mean planning time for the PIPA arm (2.38 ± 0.96 min) compared with the conventional (43.13 ± 58.70 min) technique (p >> 0.05).
CONCLUSIONS: A machine learning-based planning workflow for prostate LDR brachytherapy has the potential to offer significant time savings and operational efficiencies, while producing noninferior postoperative dosimetry to that of expert, conventional treatment planners.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brachytherapy; Dosimetry; Low-dose rate; Machine learning; Treatment planning

Mesh:

Substances:

Year:  2020        PMID: 32317241     DOI: 10.1016/j.brachy.2020.03.004

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  4 in total

Review 1.  Artificial intelligence (AI) and interventional radiotherapy (brachytherapy): state of art and future perspectives.

Authors:  Bruno Fionda; Luca Boldrini; Andrea D'Aviero; Valentina Lancellotta; Maria Antonietta Gambacorta; György Kovács; Stefano Patarnello; Vincenzo Valentini; Luca Tagliaferri
Journal:  J Contemp Brachytherapy       Date:  2020-10-30

Review 2.  Artificial intelligence in brachytherapy: a summary of recent developments.

Authors:  Susovan Banerjee; Shikha Goyal; Saumyaranjan Mishra; Deepak Gupta; Shyam Singh Bisht; Venketesan K; Kushal Narang; Tejinder Kataria
Journal:  Br J Radiol       Date:  2021-04-29       Impact factor: 3.629

Review 3.  Randomized Controlled Trials of Artificial Intelligence in Clinical Practice: Systematic Review.

Authors:  Thomas Y T Lam; Max F K Cheung; Yasmin L Munro; Kong Meng Lim; Dennis Shung; Joseph J Y Sung
Journal:  J Med Internet Res       Date:  2022-08-25       Impact factor: 7.076

4.  Artificial intelligence can overcome challenges in brachytherapy treatment planning.

Authors:  Xun Jia; J Adam M Cunha; Yi Rong
Journal:  J Appl Clin Med Phys       Date:  2022-01       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.